F270-0023 Screening compound: 2-[4-(4-chlorophenyl)-3-methyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl]-N-[2-(4-chlorophenyl)ethyl]acetamide

F270-0023 Screening compound: 2-[4-(4-chlorophenyl)-3-methyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl]-N-[2-(4-chlorophenyl)ethyl]acetamide
F270-0023 Screening compound: 2-[4-(4-chlorophenyl)-3-methyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl]-N-[2-(4-chlorophenyl)ethyl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F270-0023
2-[4-(4-chlorophenyl)-3-methyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl]-N-[2-(4-chlorophenyl)ethyl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F270-0023

Molecular Formula

C22H18Cl2N4O3 (C22 H18 Cl2 N4 O3)

Compound Name

2-[4-(4-chlorophenyl)-3-methyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl]-N-[2-(4-chlorophenyl)ethyl]acetamide

IUPAC name

2-[4-(4-chlorophenyl)-3-methyl-7-oxo-6H7H-[12]oxazolo[34-d]pyridazin-6-yl]-N-[2-(4-chlorophenyl)ethyl]acetamide

SMILES

Cc(onc12)c2C(c(cc2)ccc2Cl)=NN(CC(NCCc(cc2)ccc2Cl)=O)C1=O

InChI

InChI=1S/C22H18Cl2N4O3/c1-13-19-20(15-4-8-17(24)9-5-15)26-28(22(30)21(19)27-31-13)12-18(29)25-11-10-14-2-6-16(23)7-3-14/h2-9H,10-12H2,1H3,(H,25,29)

InChI Key

FFAKAQMYGVLAPL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27111107

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

457.32

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.249

Distribution Coefficient, logD

3.249

Water Solubility, LogSw

-4.18

Polar Surface Area

73.831

Acid Dissociation Constant (pKa)

15.06

Base Dissociation Constant (pKb)

1.54

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

18.20

F270-0023 in Drug Discovery

Included in Screening Libraries

MCL1 Targeted Library (12200 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F270-0023 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F270-0023?
Check Price and Availability of F270-0023, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F270-0023 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F270-0023
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F270-0023
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F270-0023 available by request